• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺部非结核分枝杆菌感染中的巨噬细胞信号通路。

Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.

机构信息

Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; and.

Atlanta Veterans Affairs Health Care System, Decatur, Georgia.

出版信息

Am J Respir Cell Mol Biol. 2020 Aug;63(2):144-151. doi: 10.1165/rcmb.2019-0241TR.

DOI:10.1165/rcmb.2019-0241TR
PMID:32160017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7397773/
Abstract

The incidence and prevalence of nontuberculous mycobacteria (NTM) lung disease is rising worldwide and accounts for most clinical cases of NTM disease. NTM infections occur in both immunocompetent and immunocompromised hosts. Macrophages are the primary host cells that initiate an immune response to NTM. Defining the molecular events that govern the control of infection within macrophages is fundamental to understanding the pathogenesis of NTM disease. Here, we review key macrophage host signaling pathways that contribute to the host immune response to pulmonary NTM infections. In this review, we focus primarily on NTM that are known to cause lung disease, including , , and .

摘要

非结核分枝杆菌(NTM)肺病的发病率和患病率在全球范围内呈上升趋势,占 NTM 疾病的大多数临床病例。NTM 感染发生在免疫功能正常和免疫功能低下的宿主中。巨噬细胞是引发针对 NTM 免疫反应的主要宿主细胞。定义控制巨噬细胞内感染的分子事件对于理解 NTM 疾病的发病机制至关重要。在这里,我们回顾了有助于宿主对肺部 NTM 感染产生免疫反应的关键巨噬细胞宿主信号通路。在本综述中,我们主要关注已知会导致肺病的 NTM,包括 、 、和 。

相似文献

1
Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.肺部非结核分枝杆菌感染中的巨噬细胞信号通路。
Am J Respir Cell Mol Biol. 2020 Aug;63(2):144-151. doi: 10.1165/rcmb.2019-0241TR.
2
Nontuberculous mycobacteria infections in immunosuppressed hosts.免疫抑制宿主中的非结核分枝杆菌感染
Clin Chest Med. 2015 Mar;36(1):91-9. doi: 10.1016/j.ccm.2014.11.002. Epub 2014 Dec 23.
3
Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea.韩国一家专业结核病治疗中心的非结核分枝杆菌感染情况。
BMC Infect Dis. 2017 Jun 15;17(1):432. doi: 10.1186/s12879-017-2532-4.
4
Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.人类非结核分枝杆菌肺部感染的流行病学:综述
Clin Chest Med. 2015 Mar;36(1):13-34. doi: 10.1016/j.ccm.2014.10.002. Epub 2014 Nov 6.
5
Antibiotic treatment for nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病的抗生素治疗
Expert Rev Respir Med. 2016;10(5):557-68. doi: 10.1586/17476348.2016.1165611. Epub 2016 Mar 30.
6
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.日本一家转诊医院中,非结核分枝杆菌肺病和结核病的流行病学和临床特征的相互关系变化。
Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8.
7
Inactivation of nontuberculous mycobacteria by gaseous ozone treatment.气态臭氧处理对非结核分枝杆菌的灭活作用。
J Infect Chemother. 2023 Jun;29(6):628-630. doi: 10.1016/j.jiac.2023.03.004. Epub 2023 Mar 8.
8
Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.希腊肺部疾病治疗患者中非结核分枝杆菌的分布——与微生物学数据的关系
Future Microbiol. 2015;10(8):1301-6. doi: 10.2217/FMB.15.50. Epub 2015 Jul 30.
9
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review.全球非结核分枝杆菌肺部感染的趋势:一项系统评价。
Int J Infect Dis. 2022 Dec;125:120-131. doi: 10.1016/j.ijid.2022.10.013. Epub 2022 Oct 13.
10
Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.肺部非结核分枝杆菌感染的流行病学研究进展。
Semin Respir Crit Care Med. 2013 Feb;34(1):87-94. doi: 10.1055/s-0033-1333567. Epub 2013 Mar 4.

引用本文的文献

1
Targeting Autophagy as a Strategy for Developing New Host-Directed Therapeutics Against Nontuberculous Mycobacteria.以自噬为靶点开发抗非结核分枝杆菌新型宿主导向疗法的策略
Pathogens. 2025 May 13;14(5):472. doi: 10.3390/pathogens14050472.
2
Clinicopathological characteristics and diagnostic performance of metagenomic pathogen detection technology in mycobacterial infections among HIV patients.宏基因组病原体检测技术在HIV患者分枝杆菌感染中的临床病理特征及诊断效能
Front Cell Infect Microbiol. 2025 Apr 29;15:1584189. doi: 10.3389/fcimb.2025.1584189. eCollection 2025.
3
Lung Microenvironment Among Patients with Nontuberculous Mycobacterial Pulmonary Disease by Metagenomic Sequencing Technique.采用宏基因组测序技术分析非结核分枝杆菌肺病患者的肺微环境
Biomedicines. 2025 Mar 28;13(4):818. doi: 10.3390/biomedicines13040818.
4
Recent advances in immunopathogenesis and clinical practice: mastering the challenge-managing of non-tuberculous mycobacteria.免疫发病机制与临床实践的最新进展:应对非结核分枝杆菌感染的挑战与管理
Front Immunol. 2025 Mar 19;16:1554544. doi: 10.3389/fimmu.2025.1554544. eCollection 2025.
5
PGC-1α activation to enhance macrophage immune function in mycobacterial infections.PGC-1α激活以增强巨噬细胞在分枝杆菌感染中的免疫功能。
PLoS One. 2025 Feb 6;20(2):e0310908. doi: 10.1371/journal.pone.0310908. eCollection 2025.
6
Clinical Characteristics, Species Distribution, and Drug Resistance of Non-Tuberculous Mycobacteria Lung Disease in Qingdao, China.中国青岛非结核分枝杆菌肺病的临床特征、菌种分布及耐药性
Infect Drug Resist. 2024 Nov 1;17:4807-4814. doi: 10.2147/IDR.S475015. eCollection 2024.
7
Characterization of novel double-reporter strains of for drug discovery: a study in mScarlet.用于药物发现的新型双报告菌株的表征:mScarlet 中的研究。
Microbiol Spectr. 2024 Oct 3;12(10):e0036224. doi: 10.1128/spectrum.00362-24. Epub 2024 Aug 27.
8
Immunologic features of nontuberculous mycobacterial pulmonary disease based on spatially resolved whole transcriptomics.基于空间分辨全转录组学的非结核分枝杆菌肺病的免疫学特征。
BMC Pulm Med. 2024 Aug 13;24(1):392. doi: 10.1186/s12890-024-03207-2.
9
Inhaled Corticosteroids and the Risk of Nontuberculous Mycobacterial Infection in Chronic Airway Disease: A Nationwide Population-Based Study.吸入性糖皮质激素与慢性气道疾病中非结核分枝杆菌感染风险:一项基于全国人群的研究。
Tuberc Respir Dis (Seoul). 2024 Oct;87(4):473-482. doi: 10.4046/trd.2024.0038. Epub 2024 Jun 5.
10
Itaconic acid inhibits nontuberculous mycobacterial growth in pH dependent manner while 4-octyl-itaconic acid enhances THP-1 clearance of nontuberculous mycobacteria in vitro.衣康酸以 pH 依赖的方式抑制非结核分枝杆菌的生长,而 4-辛基衣康酸则增强 THP-1 体外清除非结核分枝杆菌的能力。
PLoS One. 2024 May 10;19(5):e0303516. doi: 10.1371/journal.pone.0303516. eCollection 2024.

本文引用的文献

1
Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008-2015.2008-2015 年美国大型管理式医疗保健计划中非结核分枝杆菌肺病的发病率和患病率。
Ann Am Thorac Soc. 2020 Feb;17(2):178-185. doi: 10.1513/AnnalsATS.201804-236OC.
2
Therapeutic modulation of autophagy: which disease comes first?自噬的治疗调节:先治哪种病?
Cell Death Differ. 2019 Mar;26(4):680-689. doi: 10.1038/s41418-019-0290-0. Epub 2019 Feb 6.
3
MmpL8 controls virulence and production of a previously unknown glycolipid family.MmpL8 控制着一种先前未知的糖脂家族的毒力和产生。
Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10147-E10156. doi: 10.1073/pnas.1812984115. Epub 2018 Oct 9.
4
Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994-2014.非结核分枝杆菌性肺部感染,西班牙加泰罗尼亚,1994-2014 年。
Emerg Infect Dis. 2018 Jun;24(6):1091-1094. doi: 10.3201/eid2406.172095.
5
Update in Tuberculosis and Nontuberculous Mycobacteria 2017.2017年结核病和非结核分枝杆菌研究进展
Am J Respir Crit Care Med. 2018 May 15;197(10):1248-1253. doi: 10.1164/rccm.201801-0106UP.
6
Management of nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病的管理。
Curr Opin Pulm Med. 2018 May;24(3):212-219. doi: 10.1097/MCP.0000000000000473.
7
Identification of genes required for growth in vivo with a prominent role of the ESX-4 locus.鉴定在体内生长所必需的基因,其中 ESX-4 基因座起重要作用。
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E1002-E1011. doi: 10.1073/pnas.1713195115. Epub 2018 Jan 17.
8
Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada.加拿大安大略省肺型与非肺型非结核分枝杆菌。
Emerg Infect Dis. 2017 Nov;23(11):1898-1901. doi: 10.3201/eid2311.170959.
9
Clinical Mycobacterium abscessus strain inhibits autophagy flux and promotes its growth in murine macrophages.临床分支杆菌脓肿菌株抑制自噬通量并促进其在小鼠巨噬细胞中的生长。
Pathog Dis. 2017 Nov 30;75(8). doi: 10.1093/femspd/ftx107.
10
Increased survival and proliferation of the epidemic strain Mycobacterium abscessus subsp. massiliense CRM0019 in alveolar epithelial cells.流行株脓肿分枝杆菌亚种 CRM0019 在肺泡上皮细胞中的生存和增殖增加。
BMC Microbiol. 2017 Sep 13;17(1):195. doi: 10.1186/s12866-017-1102-7.